FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule
Dockets Management

Back


2005N-0279
BKG 1
Volume 1

Reference List

Reference 1 - National Institutes of Health (NM) (2004). Consensus statement on celiac disease, June 28-30. Accessible on June 2005 at http://consensus.nih.gov/cons/118/118celiacPDF.pdf

Reference 2 - Kasarda, D. D. (2001). Grains in relation to celiac disease. CerealFoods World, 46(5):209-10. Published Material

Reference 3 - Janatuinen, E. K., Kemppainen, T. A., Julkunen, R. J., Kosma, V. M., Maki, M., Heikkinen,M., Uusitupa, M. I. (2002). No harm from five year ingestion of oats in coeliac disease. Gut, 50(3): 332-335. Published Material

Reference 4 - Janatuinen, E. K., Kemppainen, T. A., Pikkarainen, P. H., Holm, K. H., Kosma, V.M., Uusitupa, M.I., Maki, M., Julkunen, R. J. (2000). Lack of cellular and humoral immunological responses to oats in adults with coeliac disease, Gut, 46(3): 327-331. Published Material

Reference 5 - Janatuinen, E. K., Pikkarainen, P. H., Kemppainen, T. A., Kosma, V. M., Jarvinen, R. M., Uusitupa, M. I., Julkunen, R. J. (1995). A Comparison of Diets with and without Oats in Adults with Celiac Disease. N Eng J Med, 333(16): 1033-1037. Published Material

Reference 6 - Lundin, K. E., Nilsen, EM., Scott, H.G., Loberg, E. M., Gjoen, A., Bratlie, J., Skar, V., Mendez, E., Lovik, A., Kett, K. (2003). Oats induced viflous atrophy in coeliac disease. Gut, 52(11): 1649-1652. Published Material

Reference 7 - Arentz-Hansen, H., Fleckenstein, B., Molberg, O., Scott, H., Koning, F., Jung, G., Roepstorff: P., Lundin, K. E., Sollid, L. M, (2004). The molecular basis for oat intolerance in patients with celiac disease. Plos Med, 1: 84-92. Published Material

Reference 8 - Thompson, T. (2004), Gluten contamination of commercial oat products in the United States.N Engl J Med, 351(19): 2021-2022. Published Material

Reference 9 - Brown A. (2004) Understanding Food Principles and Preparation, Second Edition. Wadsworth/Thomson Learning, Belmont CA, USA, p. 402-403. Published Material

Reference 10 - Corrao, G., Corazza, G. R., Bagnardi, V., Brusco, G., Ciacci, C., Cottone, M., Sategna Guidetti, C., Usai, P., Cesari, P., Pelli, M. A., Loperfido, S., Volta, U., Calabro, A., Certo, M. (2001). Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet, 358: 356-361. Published Material

Reference 11 - Dewar, D., Pereira, S. P., Ciclitira, P. J. (2004). The pathogenesis of coeliac disease. Int J Biochem Cell Biol, 36: 17-24. Published Material

Reference 12 - Fasano, A. and Catassi, C. (2001). Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum, Gastroenterology, 120(3): 636-651. Published Material


Top | Back

Page last updated August 12, 2005 RSChorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management